Peptide Blends
Growth-hormone pathway support in one blend
01
Pairs Tesamorelin (a GHRH analog) and Ipamorelin (a GH secretagogue)
02
Studied pathways focus on growth hormone and body composition
03
Combines a GHRH-receptor and a ghrelin-receptor (GHS-R) approach
A peptide blend pairing Tesamorelin and Ipamorelin for users comparing growth hormone and body-composition options.
Choose your plan
Peptide checkout1. Purchase type
2. Choose billing term
How this plan works
Pay
$726.30 today
Renews every 3 months
Ship
Every 3 months
After provider approval
Refills
Paid quarterly
Continues until canceled
A U.S.-licensed provider reviews your request before it ships. If you are not approved, you are refunded in full.
Quick answer
A peptide blend pairing Tesamorelin and Ipamorelin for users comparing growth hormone and body-composition options.
Format
Blend
Best use
Peptide Blends
Evidence
Research-framed
Deep research
This blend pairs Tesamorelin (a stabilized GHRH analog) with Ipamorelin (a selective growth hormone secretagogue that acts at the ghrelin/GHS receptor). It is positioned for users comparing growth hormone and body-composition research options in a single co-formulated vial.
It is stored lyophilized at -20C and reconstituted with bacteriostatic water, then refrigerated at 2-8C.
Key benefits
Pairs Tesamorelin (a GHRH analog) and Ipamorelin (a GH secretagogue)
Studied pathways focus on growth hormone and body composition
Combines a GHRH-receptor and a ghrelin-receptor (GHS-R) approach
Single vial is simpler than building a separate two-item cart
Mechanism
Research describes the two peptides acting on different but complementary pathways: Tesamorelin at the GHRH receptor on pituitary somatotrophs, and Ipamorelin at the growth hormone secretagogue receptor (GHS-R). Both are studied for their role in physiological GH release while pituitary feedback remains intact.
Questions people ask
Research describes them acting on complementary receptors (GHRH receptor and ghrelin/GHS receptor), both studied for their role in physiological GH release.
It is stored lyophilized at -20C and reconstituted with bacteriostatic water, then refrigerated at 2-8C.
Concentration
Tesamorelin 15mg + Ipamorelin 10mg
Purity
99.0%
Format
Blend
Vial
5mL vial
Compare next
Growth & Performance
Tesamorelin
GHRH analog studied in research for visceral-fat and body composition
View →
Peptide Blends
MOTS-C / Tesamorelin Blend
Metabolic and mitochondrial support in one peptide blend
View →
Metabolic & Fat Loss
MOTS-c
A mitochondrial-derived peptide studied in metabolic research
View →